Homozygous P86S Mutation of the Human Glucagon Receptor is Associated with Hyperglucagonemia, Alpha Cell Hyperplasia, and Islet Cell Tumor

Overview

Journal Pancreas

Specialty Gastroenterology

Date 2009 Aug 7

PMID 19657311

Citations 55

Authors

Cuiqi Zhou

Deepti Dhall

Nicholas N Nissen

Chun-Rong Chen

Run Yu

Affiliations

Soon will be listed here.

Abstract

Objective: The goal of the study was to investigate the genetic and molecular basis of a novel syndrome of marked hyperglucagonemia and pancreatic alpha cell hyperplasia without glucagonoma syndrome.

Methods: The glucagon receptor (GCGR) gene and the glucagon gene were sequenced in a patient with hyperglucagonemia and pancreatic alpha cell hyperplasia without glucagonoma syndrome. Enhanced green fluorescent protein-conjugated wild type (WT) and mutant GCGR were used to characterize the functions of the mutant GCGR.

Results: The glucagon gene sequence was normal, but the GCGR sequencing uncovered a homozygous missense mutation, c.256C>T, p.P86S in the extracellular domain of GCGR. When expressed in human embryonic kidney 293 cells, GCGR P86S localized to the plasma membrane but bound 96% less radiolabeled glucagon than WT GCGR. The median effective concentration of glucagon-induced cyclic adenosine monophosphate production was 24 nmol/L for GCGR P86S but 2.4 nmol/L for WT GCGR. The patient's alpha cells also express glucagonlike peptide 1 and pancreatic polypeptide.

Conclusions: We hereby report the first homozygous missense mutation in the human GCGR, which is associated with alpha cell hyperplasia and hyperglucagonemia. This mutation lowers the receptor's affinity to glucagon and decreases cyclic adenosine monophosphate production with physiological concentrations of glucagon. Thus, the P86S mutation in GCGR likely causes alpha cell hyperplasia and hyperglucagonemia.

Citing Articles

Neuroendocrine Tumors: Germline Genetics and Hereditary Syndromes.

Lauricella E, Chaoul N, DAngelo G, Giglio A, Cafiero C, Porta C Curr Treat Options Oncol. 2025; 26(1):55-71.

PMID: 39821711 DOI: 10.1007/s11864-024-01288-z.

Absence of PNET formation and normal longevity in a mouse model of Mahvash disease.

Xu Y, Liu Q, Chen C, Wang Q, Du T, Yu R Heliyon. 2024; 10(15):e35362.

PMID: 39170309 PMC: 11336617. DOI: 10.1016/j.heliyon.2024.e35362.

Glucagon resistance and metabolic-associated steatotic liver disease: a review of the evidence.

McGlone E, Bloom S, Tan T J Endocrinol. 2024; 261(3).

PMID: 38579751 PMC: 11067060. DOI: 10.1530/JOE-23-0365.

Genotype-histotype-phenotype correlations in hyperinsulinemic hypoglycemia.

Larsen A, Brusgaard K, Christesen H, Detlefsen S Histol Histopathol. 2024; 39(7):817-844.

PMID: 38305063 DOI: 10.14670/HH-18-709.

[Multiple neuroendocrine tumors of the pancreas].

Sipos B Pathologie (Heidelb). 2024; 45(1):28-34.

PMID: 38180510 DOI: 10.1007/s00292-023-01289-z.

References

Spiegel A, Weinstein L . Inherited diseases involving g proteins and g protein-coupled receptors. Annu Rev Med. 2004; 55:27-39. DOI: 10.1146/annurev.med.55.091902.103843. View

Thyssen S, Arany E, Hill D . Ontogeny of regeneration of beta-cells in the neonatal rat after treatment with streptozotocin. Endocrinology. 2006; 147(5):2346-56. DOI: 10.1210/en.2005-0396. View

Hager J, Hansen L, Vaisse C, Vionnet N, Philippi A, Poller W . A missense mutation in the glucagon receptor gene is associated with non-insulin-dependent diabetes mellitus. Nat Genet. 1995; 9(3):299-304. DOI: 10.1038/ng0395-299. View

Lubensky I, Pack S, Ault D, Vortmeyer A, Libutti S, Choyke P . Multiple neuroendocrine tumors of the pancreas in von Hippel-Lindau disease patients: histopathological and molecular genetic analysis. Am J Pathol. 1998; 153(1):223-31. PMC: 1852951. DOI: 10.1016/S0002-9440(10)65563-0. View

Thompson N, Lloyd R, NISHIYAMA R, Vinik A, Strodel W, Allo M . MEN I pancreas: a histological and immunohistochemical study. World J Surg. 1984; 8(4):561-74. DOI: 10.1007/BF01654938. View

Henopp T, Anlauf M, Schmitt A, Schlenger R, Zalatnai A, Couvelard A . Glucagon cell adenomatosis: a newly recognized disease of the endocrine pancreas. J Clin Endocrinol Metab. 2008; 94(1):213-7. DOI: 10.1210/jc.2008-1300. View

Gromada J, Franklin I, Wollheim C . Alpha-cells of the endocrine pancreas: 35 years of research but the enigma remains. Endocr Rev. 2007; 28(1):84-116. DOI: 10.1210/er.2006-0007. View

Mayo K, Miller L, Bataille D, Dalle S, Goke B, Thorens B . International Union of Pharmacology. XXXV. The glucagon receptor family. Pharmacol Rev. 2003; 55(1):167-94. DOI: 10.1124/pr.55.1.6. View

Wilson M, Kalamaras J, German M . Expression pattern of IAPP and prohormone convertase 1/3 reveals a distinctive set of endocrine cells in the embryonic pancreas. Mech Dev. 2002; 115(1-2):171-6. DOI: 10.1016/s0925-4773(02)00118-1. View

10.

Martignoni M, Kated H, Stiegler M, Buchler M, Friess H, Zimmermann A . Nesidioblastosis with glucagon-reactive islet cell hyperplasia: a case report. Pancreas. 2003; 26(4):402-5. DOI: 10.1097/00006676-200305000-00016. View

11.

Odawara M, Tachi Y, Yamashita K . Absence of association between the Gly40-->Ser mutation in the human glucagon receptor and Japanese patients with non-insulin-dependent diabetes mellitus or impaired glucose tolerance. Hum Genet. 1996; 98(6):636-9. DOI: 10.1007/s004390050274. View

12.

Gelling R, Du X, Dichmann D, Romer J, Huang H, Cui L . Lower blood glucose, hyperglucagonemia, and pancreatic alpha cell hyperplasia in glucagon receptor knockout mice. Proc Natl Acad Sci U S A. 2003; 100(3):1438-43. PMC: 298791. DOI: 10.1073/pnas.0237106100. View

13.

Vuguin P, Kedees M, Cui L, Guz Y, Gelling R, Nejathaim M . Ablation of the glucagon receptor gene increases fetal lethality and produces alterations in islet development and maturation. Endocrinology. 2006; 147(9):3995-4006. PMC: 4287247. DOI: 10.1210/en.2005-1410. View

14.

Chastain M . The glucagonoma syndrome: a review of its features and discussion of new perspectives. Am J Med Sci. 2001; 321(5):306-20. DOI: 10.1097/00000441-200105000-00003. View

15.

Runge S, Thogersen H, Madsen K, Lau J, Rudolph R . Crystal structure of the ligand-bound glucagon-like peptide-1 receptor extracellular domain. J Biol Chem. 2008; 283(17):11340-7. DOI: 10.1074/jbc.M708740200. View

16.

Yu R, Nissen N, Dhall D, Heaney A . Nesidioblastosis and hyperplasia of alpha cells, microglucagonoma, and nonfunctioning islet cell tumor of the pancreas: review of the literature. Pancreas. 2008; 36(4):428-31. DOI: 10.1097/MPA.0b013e31815ceb23. View

17.

Parthier C, Kleinschmidt M, Neumann P, Rudolph R, Manhart S, Schlenzig D . Crystal structure of the incretin-bound extracellular domain of a G protein-coupled receptor. Proc Natl Acad Sci U S A. 2007; 104(35):13942-7. PMC: 1955799. DOI: 10.1073/pnas.0706404104. View

18.

Unson C, Cypess A, Kim H, Goldsmith P, Carruthers C, MERRIFIELD R . Characterization of deletion and truncation mutants of the rat glucagon receptor. Seven transmembrane segments are necessary for receptor transport to the plasma membrane and glucagon binding. J Biol Chem. 1995; 270(46):27720-7. DOI: 10.1074/jbc.270.46.27720. View

19.

Umino Y, Everhart D, Solessio E, Cusato K, Pan J, Nguyen T . Hypoglycemia leads to age-related loss of vision. Proc Natl Acad Sci U S A. 2006; 103(51):19541-5. PMC: 1697832. DOI: 10.1073/pnas.0604478104. View

20.

Hansen L, Abrahamsen N, Hager J, Jelinek L, Kindsvogel W, Froguel P . The Gly40Ser mutation in the human glucagon receptor gene associated with NIDDM results in a receptor with reduced sensitivity to glucagon. Diabetes. 1996; 45(6):725-30. DOI: 10.2337/diab.45.6.725. View